including the 10 that involve target sequences of therapeutics.
"The fındings in no way reduce the value of viral targeted therapeutics," says Palacios. "However, they do highlight a potential and continuing challenge for their development and maintenance. This work needs to be continued as the outbreak progresses." Fortunately, he adds, "some of the therapeutics have been deliberately designed to be tolerant to possible target mutation: for example, siRNAs and PMOs were targeted to areas of higher conservation where mutation was thought to be unlikely."
"To some extent, this article is comforting," says Tom Ksiazek of the University of Texas Medical Branch, Galveston National Laboratories in Galveston, Texas. "There are changes, but they are not major," he adds, referring to the circulating strain of Ebola virus. "But we do need to keep following this."
A major impetus for this analysis was inquiries from policy makers, drug developers, and public health offıcials, according to Palacios. There was widespread speculation as the outbreak was developing that the current version of the Ebola virus differed dramatically from earlier versions, perhaps explaining how rapidly the outbreak expanded. However, "We provided this report immediately to them and made it public as soon as was possible," he says.
Although 
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Artful Approach by Gates Foundation, Promoting Vaccines Carrie Arnold
To promote vaccine usage and development, the Bill and Melinda Gates Foundation recently launched the "Art of Saving a Life," a campaign that commissioned more than 30 photographers, painters, sculptors, writers, fılm-makers, and musicians to portray colorful stories about immunization, past and present. The idea behind this campaign is to fınd new ways of convincing the general public of the value of vaccines in preventing disease and improving public health.
The idea came to Gates Foundation consultant Christine McNab while on an afternoon run near her home in Bangkok. Instead of talking and writing about vaccines, she could commission artists to tell the stories of vaccines in different and creative ways. "I wanted a fresh way to talk about vaccines and get the message out that vaccines are effective," she says. "Arts are a way to people's emotions that you don't get with a news release."
Soon after McNab shared her idea with offıcials of the Gates Foundation, they agreed to give it a try. Instead of staging a traditional art exhibit, McNab opted for a virtual approach by developing an online project that is available to anyone with access to the Internet and is apt to be persuaded to visit that website via social media (www.artof savingalife.com/).
Meanwhile, she identifıed awardwinning artists, inviting them to contribute their work to the project after giving them a general idea of what she was seeking and then letting their creativity run free. For example, even before hearing from McNab, Australian photographer Alexia Sinclair was already thinking about vaccines and how much they mean for her then fourmonth-old daughter, who was regularly receiving her immunizations to ward off childhood diseases.
However, Sinclair took a broader look at this subject as she decided how she wanted to contribute to the campaign. "Since smallpox is the greatest killer in human history, and the only disease to have been completely eradicated from the planet, I naturally felt a lot of pressure to make an artwork that respected the story of Edward Jenner's
MINITOPIC
Microbiota of the New York Subways: Token of My Infections?
Although the subways of New York no longer accept tokens, the system continues to harbor its own special mix of microbiota, according to Christopher E. Mason of Weill Cornell Medical College in New York, N.Y., and his collaborators. "Most bacteria in these densely populated, highly trafficked transit areas are neutral to human health, and much of it is commonly found on the skin or in the gastrointestinal tract," he says. Mason and his collaborators present their analysis of the distribution of that microbiota in a "PathoMap," noting that it contains evidence of some pathogens such as Bacillus anthracis being present, but that they do not appear to be causing disease and, instead, appear to be part of a "normal, urban microbiome." Although nearly half the DNA (48%) that was analyzed "does not match any known organism," the organisms that could be identified "spanned 1,688 bacterial, viral, archaeal, and eukaryotic taxa," the researchers note. Details appeared 7 February 2015 in Cell Systems (doi: 10.1016/j.cels.2015.01.001).
inoculation as well as producing a powerful artwork that contemporary audiences could relate," she says. After learning that the Chinese word for smallpox could be translated as "heavenly flowers," she staged an 18th-century tableau suggesting how smallpox once affected even the highest levels of society.
The smallpox story also appealed to someone else whom McNab contacted-Vik Muniz, a Brazilian-born artist now living in New York, N.Y. Working with bioengineer Tal Danino, a postdoc at the Massachusetts Institute of Technology, they molded their art at the micro level, building on several years of collaboration, focusing on cell cultures, and using microfabrication techniques and high-resolution microscopy. For the Gates Foundation project, they created what appears to be a print of flowers that, when looked at more closely, consists of electron micrographs showing the vaccinia virus escaping from liver cells. "Art is a lot easier for people to understand and digest than scientifıc jargon," Danino says. "Everyone can understand a picture."
This artwork will be used to help increase funding for Gavi, The Vaccine Alliance, according to McNab, by promoting conversations about vaccines. The project was offıcially unveiled on 27 January at a high-level event in Germany that brought together world leaders and NGOs to support Gavi and bring vaccines to the world's children. Based on their analysis of some 15,000 soil samples from 365 sites, researchers from 35 institutions around the world recently revised the estimate of global fungal species downward by 1.5-to 2.5-fold from previous estimates, which range from 0.8 million to 5.1 million species. Notably, fungal species richness declines with distance from the equator and at least for some specialist groups of fungi, "diversity depends more on the abundance of host plants than host diversity or geography," notes Leho Tedersoo of the University of Tartu Natural History Museum in Tartu, Estonia, who managed the project. Details appeared 28 November 2014 in Science (doi:10.1126/science. 1256688).
"Our lab had a lot of experience in working in exotic ecosystems, and therefore we took the lead in inviting participants and coordinating the work," Tedersoo says. "Nobody actually knows how many fungi there are, and it's likely that no one ever will." To estimate fungal richness, earlier investigators used estimates based on the fungi-to-plant species ratio, which they assumed to be constant across different ecosystems,Tedersoocontinues. However, "we showed that this is not true. It is mostly climate that drives fungal richness and com- 
